These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1908106)

  • 1. Deamination of 2-propyl-1-aminopentane and 2-[(2-propyl)pentylamino] acetamide by amine oxidases: formation of valproic acid.
    Yu PH; Davis BA
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(2):303-6. PubMed ID: 1908106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some pharmacological implications of MAO-mediated deamination of branched aliphatic amines: 2-propyl-1-aminopentane and N-(2-propylpentyl)glycinamide as valproic acid precursors.
    Yu PH; Davis BA
    J Neural Transm Suppl; 1990; 32():89-92. PubMed ID: 2128515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-propyl-1-aminopentane, its deamination by monoamine oxidase and semicarbazide-sensitive amine oxidase, conversion to valproic acid and behavioral effects.
    Yu PH; Davis BA
    Neuropharmacology; 1991 May; 30(5):507-15. PubMed ID: 1865997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous delivery of valproic acid and glycine to the brain. Deamination of 2-propylpentylglycinamide by monoamine oxidase B.
    Yu PH; Davis BA
    Mol Chem Neuropathol; 1991 Aug; 15(1):37-49. PubMed ID: 1772533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deamination of aliphatic amines by type B monoamine oxidase and semicarbazide-sensitive amine oxidase; pharmacological implications.
    Yu PH; Davis BA; Boulton AA; Zuo DM
    J Neural Transm Suppl; 1994; 41():397-406. PubMed ID: 7931256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The deamination of n-pentylamine by monoamine oxidase and a semicarbazide-sensitive amine oxidase of rat heart.
    Guffroy C; Fowler CJ; Strolin Benedetti M
    J Pharm Pharmacol; 1983 Jul; 35(7):416-20. PubMed ID: 6136581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative deamination of aliphatic amines by rat aorta semicarbazide-sensitive amine oxidase.
    Yu PH
    J Pharm Pharmacol; 1990 Dec; 42(12):882-4. PubMed ID: 1983156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of fat deposition by combined inhibition of monoamine oxidases and semicarbazide-sensitive amine oxidases in obese Zucker rats.
    Carpéné C; Iffiú-Soltesz Z; Bour S; Prévot D; Valet P
    Pharmacol Res; 2007 Dec; 56(6):522-30. PubMed ID: 17977742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some aspects of the pharmacology of semicarbazide-sensitive amine oxidases.
    Callingham BA; Holt A; Elliott J
    J Neural Transm Suppl; 1990; 32():279-90. PubMed ID: 2128500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term insulin-like effects of monoamine oxidases and semicarbazide-sensitive amine oxidase substrates in cultured adipocytes.
    Carpéné C; Daviaud D; Boucher J; Bour S; Visentin V; Grès S; Duffaut C; Fontana E; Testar X; Saulnier-Blache JS; Valet P
    Metabolism; 2006 Oct; 55(10):1397-405. PubMed ID: 16979412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semicarbazide-sensitive amine oxidase and monoamine oxidase in rat brain microvessels, meninges, retina and eye sclera.
    Zuo DM; Yu PH
    Brain Res Bull; 1994; 33(3):307-11. PubMed ID: 8293314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate selectivity of monoamine oxidase A, monoamine oxidase B, diamine oxidase, and semicarbazide-sensitive amine oxidase in COS-1 expression systems.
    Ochiai Y; Itoh K; Sakurai E; Adachi M; Tanaka Y
    Biol Pharm Bull; 2006 Dec; 29(12):2362-6. PubMed ID: 17142964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semicarbazide-sensitive amine oxidase (SSAO) in the brain.
    Obata T
    Neurochem Res; 2002 Apr; 27(4):263-8. PubMed ID: 11958526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vivo effects of (E)-2-(3',4'-dimethoxyphenyl)-3-fluoroallylamine (MDL 72145) on amine oxidase activities in the rat. Selective inhibition of semicarbazide-sensitive amine oxidase in vascular and brown adipose tissues.
    Elliott J; Callingham BA; Barrand MA
    J Pharm Pharmacol; 1989 Jan; 41(1):37-41. PubMed ID: 2565962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity.
    O'Rourke AM; Wang EY; Miller A; Podar EM; Scheyhing K; Huang L; Kessler C; Gao H; Ton-Nu HT; Macdonald MT; Jones DS; Linnik MD
    J Pharmacol Exp Ther; 2008 Feb; 324(2):867-75. PubMed ID: 17993604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related changes in the activities of the amine metabolizing enzymes of rat eye.
    Cao Danh H; Strolin Benedetti M; Mousset A; Pasquier-Béchet P
    J Pharm Pharmacol; 1985 May; 37(5):357-61. PubMed ID: 2862249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deamination of methylamine by semicarbazide-sensitive amine oxidase in human umbilical artery and rat aorta.
    Precious E; Gunn CE; Lyles GA
    Biochem Pharmacol; 1988 Feb; 37(4):707-13. PubMed ID: 3342102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of tresperimus by rat aorta semicarbazide-sensitive amine oxidase (SSAO).
    Claud P; Artur Y; Guichard JP; Laine R
    Fundam Clin Pharmacol; 2002 Dec; 16(6):461-70. PubMed ID: 12685504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of chronic administration of inhibitors of flavin and quinone amine oxidases on imidazoline I(1) receptor density in rat whole brain.
    Holt A; Todd KG; Baker GB
    Ann N Y Acad Sci; 2003 Dec; 1009():309-22. PubMed ID: 15028605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amine oxidases as important agents of pathological processes of rhabdomyolysis in rats.
    Gudkova OO; Latyshko NV; Shandrenko SG
    Ukr Biochem J; 2016; 88(1):79-87. PubMed ID: 29227084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.